PATENT CLAIM ANALYSIS

Application Number: 16103675
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "614000"]

Abstract:
The present invention provides compositions of therapeutic agents and methods of use for reducing and/or treating gastrointestinal inflammation. In particular aspects, the tungstate salts described herein and pharmaceutical compositions thereof inhibit the activity of one or a plurality of anaerobic respiratory enzymes in facultative anaerobic bacteria such as, for example, Enterobacteriaceae, that can exacerbate inflammation. In particular embodiments, the present invention provides compositions of therapeutic agents for treating gastrointestinal inflammation, as well as methods for treating or preventing gut microbial imbalance due to an increase in the abundance of intestinal Enterobacteriaceae.

Claim (Index 14):
The method of  claim 10 , wherein the gastrointestinal inflammation comprises colitis.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 96.0
- Lexical Diversity: 1.66667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14964487', '10412151', '15630766', '15664150', '15103372']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7222077110983207
- 35 USC 102 Novelty (BERT): 0.6050091963298928
- Combined Prediction Score: 0.710487859621478
- Mean Citation Score: 294.553448
- Max Citation Score: 653.42413
- Similarity Product: 436.4758571719634

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test